Stock Analysis on Net
Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

듀퐁 분석: ROE, ROA및 순이익률의 세분화 
분기별 데이터

Microsoft Excel

분해 ROE 는 순이익을 주주 자본으로 나눈 값을 구성 요소 비율의 곱으로 표현하는 것을 포함합니다.

ROE 두 가지 구성 요소로 세분화

Vertex Pharmaceuticals Inc., ROE 분해 (분기별 데이터)

Microsoft Excel
ROE = ROA × 재무 레버리지 비율
2024. 12. 31. -3.26% = -2.38% × 1.37
2024. 9. 30. -3.07% = -2.16% × 1.42
2024. 6. 30. -3.32% = -2.43% × 1.36
2024. 3. 31. 21.67% = 16.81% × 1.29
2023. 12. 31. 20.59% = 15.92% × 1.29
2023. 9. 30. 21.01% = 15.97% × 1.32
2023. 6. 30. 21.75% = 16.54% × 1.32
2023. 3. 31. 22.59% = 17.18% × 1.31
2022. 12. 31. 23.88% = 18.30% × 1.30
2022. 9. 30. 25.12% = 19.59% × 1.28
2022. 6. 30. 26.77% = 20.50% × 1.31
2022. 3. 31. 22.47% = 17.19% × 1.31
2021. 12. 31. 23.19% = 17.44% × 1.33
2021. 9. 30. 22.83% = 17.25% × 1.32
2021. 6. 30. 21.66% = 16.30% × 1.33
2021. 3. 31. 30.76% = 22.80% × 1.35
2020. 12. 31. 31.22% = 23.07% × 1.35
2020. 9. 30. — = — × 1.39
2020. 6. 30. — = — × 1.36
2020. 3. 31. — = — × 1.38

보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-Q (보고 날짜: 2024-09-30), 10-Q (보고 날짜: 2024-06-30), 10-Q (보고 날짜: 2024-03-31), 10-K (보고 날짜: 2023-12-31), 10-Q (보고 날짜: 2023-09-30), 10-Q (보고 날짜: 2023-06-30), 10-Q (보고 날짜: 2023-03-31), 10-K (보고 날짜: 2022-12-31), 10-Q (보고 날짜: 2022-09-30), 10-Q (보고 날짜: 2022-06-30), 10-Q (보고 날짜: 2022-03-31), 10-K (보고 날짜: 2021-12-31), 10-Q (보고 날짜: 2021-09-30), 10-Q (보고 날짜: 2021-06-30), 10-Q (보고 날짜: 2021-03-31), 10-K (보고 날짜: 2020-12-31), 10-Q (보고 날짜: 2020-09-30), 10-Q (보고 날짜: 2020-06-30), 10-Q (보고 날짜: 2020-03-31).

ROE 세 가지 구성 요소로 세분화

Vertex Pharmaceuticals Inc., ROE 분해 (분기별 데이터)

Microsoft Excel
ROE = 순이익률(Net Profit Margin Ratio) × 자산 회전율 × 재무 레버리지 비율
2024. 12. 31. -3.26% = -4.86% × 0.49 × 1.37
2024. 9. 30. -3.07% = -4.52% × 0.48 × 1.42
2024. 6. 30. -3.32% = -4.74% × 0.51 × 1.36
2024. 3. 31. 21.67% = 39.46% × 0.43 × 1.29
2023. 12. 31. 20.59% = 36.68% × 0.43 × 1.29
2023. 9. 30. 21.01% = 35.94% × 0.44 × 1.32
2023. 6. 30. 21.75% = 35.40% × 0.47 × 1.32
2023. 3. 31. 22.59% = 35.40% × 0.49 × 1.31
2022. 12. 31. 23.88% = 37.20% × 0.49 × 1.30
2022. 9. 30. 25.12% = 37.62% × 0.52 × 1.28
2022. 6. 30. 26.77% = 38.26% × 0.54 × 1.31
2022. 3. 31. 22.47% = 30.84% × 0.56 × 1.31
2021. 12. 31. 23.19% = 30.92% × 0.56 × 1.33
2021. 9. 30. 22.83% = 30.52% × 0.57 × 1.32
2021. 6. 30. 21.66% = 29.80% × 0.55 × 1.33
2021. 3. 31. 30.76% = 43.06% × 0.53 × 1.35
2020. 12. 31. 31.22% = 43.70% × 0.53 × 1.35
2020. 9. 30. — = — × — × 1.39
2020. 6. 30. — = — × — × 1.36
2020. 3. 31. — = — × — × 1.38

보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-Q (보고 날짜: 2024-09-30), 10-Q (보고 날짜: 2024-06-30), 10-Q (보고 날짜: 2024-03-31), 10-K (보고 날짜: 2023-12-31), 10-Q (보고 날짜: 2023-09-30), 10-Q (보고 날짜: 2023-06-30), 10-Q (보고 날짜: 2023-03-31), 10-K (보고 날짜: 2022-12-31), 10-Q (보고 날짜: 2022-09-30), 10-Q (보고 날짜: 2022-06-30), 10-Q (보고 날짜: 2022-03-31), 10-K (보고 날짜: 2021-12-31), 10-Q (보고 날짜: 2021-09-30), 10-Q (보고 날짜: 2021-06-30), 10-Q (보고 날짜: 2021-03-31), 10-K (보고 날짜: 2020-12-31), 10-Q (보고 날짜: 2020-09-30), 10-Q (보고 날짜: 2020-06-30), 10-Q (보고 날짜: 2020-03-31).

ROE를 5개 구성 요소로 세분화

Vertex Pharmaceuticals Inc., ROE 분해 (분기별 데이터)

Microsoft Excel
ROE = 세금 부담 × 이자 부담 × EBIT 마진 × 자산 회전율 × 재무 레버리지 비율
2024. 12. 31. -3.26% = -2.16 × 0.89 × 2.53% × 0.49 × 1.37
2024. 9. 30. -3.07% = -1.85 × 0.87 × 2.80% × 0.48 × 1.42
2024. 6. 30. -3.32% = -2.28 × 0.84 × 2.48% × 0.51 × 1.36
2024. 3. 31. 21.67% = 0.84 × 0.99 × 47.23% × 0.43 × 1.29
2023. 12. 31. 20.59% = 0.83 × 0.99 × 44.83% × 0.43 × 1.29
2023. 9. 30. 21.01% = 0.81 × 0.99 × 45.10% × 0.44 × 1.32
2023. 6. 30. 21.75% = 0.78 × 0.99 × 45.81% × 0.47 × 1.32
2023. 3. 31. 22.59% = 0.78 × 0.99 × 45.83% × 0.49 × 1.31
2022. 12. 31. 23.88% = 0.78 × 0.99 × 48.01% × 0.49 × 1.30
2022. 9. 30. 25.12% = 0.81 × 0.99 × 46.95% × 0.52 × 1.28
2022. 6. 30. 26.77% = 0.81 × 0.99 × 47.81% × 0.54 × 1.31
2022. 3. 31. 22.47% = 0.86 × 0.98 × 36.80% × 0.56 × 1.31
2021. 12. 31. 23.19% = 0.86 × 0.98 × 36.86% × 0.56 × 1.33
2021. 9. 30. 22.83% = 0.79 × 0.98 × 39.42% × 0.57 × 1.32
2021. 6. 30. 21.66% = 0.83 × 0.98 × 36.99% × 0.55 × 1.33
2021. 3. 31. 30.76% = 0.84 × 0.98 × 52.07% × 0.53 × 1.35
2020. 12. 31. 31.22% = 0.87 × 0.98 × 51.16% × 0.53 × 1.35
2020. 9. 30. — = — × — × — × — × 1.39
2020. 6. 30. — = — × — × — × — × 1.36
2020. 3. 31. — = — × — × — × — × 1.38

보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-Q (보고 날짜: 2024-09-30), 10-Q (보고 날짜: 2024-06-30), 10-Q (보고 날짜: 2024-03-31), 10-K (보고 날짜: 2023-12-31), 10-Q (보고 날짜: 2023-09-30), 10-Q (보고 날짜: 2023-06-30), 10-Q (보고 날짜: 2023-03-31), 10-K (보고 날짜: 2022-12-31), 10-Q (보고 날짜: 2022-09-30), 10-Q (보고 날짜: 2022-06-30), 10-Q (보고 날짜: 2022-03-31), 10-K (보고 날짜: 2021-12-31), 10-Q (보고 날짜: 2021-09-30), 10-Q (보고 날짜: 2021-06-30), 10-Q (보고 날짜: 2021-03-31), 10-K (보고 날짜: 2020-12-31), 10-Q (보고 날짜: 2020-09-30), 10-Q (보고 날짜: 2020-06-30), 10-Q (보고 날짜: 2020-03-31).

ROA 두 가지 구성 요소로 세분화

Vertex Pharmaceuticals Inc., ROA 분해 (분기별 데이터)

Microsoft Excel
ROA = 순이익률(Net Profit Margin Ratio) × 자산 회전율
2024. 12. 31. -2.38% = -4.86% × 0.49
2024. 9. 30. -2.16% = -4.52% × 0.48
2024. 6. 30. -2.43% = -4.74% × 0.51
2024. 3. 31. 16.81% = 39.46% × 0.43
2023. 12. 31. 15.92% = 36.68% × 0.43
2023. 9. 30. 15.97% = 35.94% × 0.44
2023. 6. 30. 16.54% = 35.40% × 0.47
2023. 3. 31. 17.18% = 35.40% × 0.49
2022. 12. 31. 18.30% = 37.20% × 0.49
2022. 9. 30. 19.59% = 37.62% × 0.52
2022. 6. 30. 20.50% = 38.26% × 0.54
2022. 3. 31. 17.19% = 30.84% × 0.56
2021. 12. 31. 17.44% = 30.92% × 0.56
2021. 9. 30. 17.25% = 30.52% × 0.57
2021. 6. 30. 16.30% = 29.80% × 0.55
2021. 3. 31. 22.80% = 43.06% × 0.53
2020. 12. 31. 23.07% = 43.70% × 0.53
2020. 9. 30. — = — × —
2020. 6. 30. — = — × —
2020. 3. 31. — = — × —

보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-Q (보고 날짜: 2024-09-30), 10-Q (보고 날짜: 2024-06-30), 10-Q (보고 날짜: 2024-03-31), 10-K (보고 날짜: 2023-12-31), 10-Q (보고 날짜: 2023-09-30), 10-Q (보고 날짜: 2023-06-30), 10-Q (보고 날짜: 2023-03-31), 10-K (보고 날짜: 2022-12-31), 10-Q (보고 날짜: 2022-09-30), 10-Q (보고 날짜: 2022-06-30), 10-Q (보고 날짜: 2022-03-31), 10-K (보고 날짜: 2021-12-31), 10-Q (보고 날짜: 2021-09-30), 10-Q (보고 날짜: 2021-06-30), 10-Q (보고 날짜: 2021-03-31), 10-K (보고 날짜: 2020-12-31), 10-Q (보고 날짜: 2020-09-30), 10-Q (보고 날짜: 2020-06-30), 10-Q (보고 날짜: 2020-03-31).

ROA를 4개의 구성 요소로 세분화

Vertex Pharmaceuticals Inc., ROA 분해 (분기별 데이터)

Microsoft Excel
ROA = 세금 부담 × 이자 부담 × EBIT 마진 × 자산 회전율
2024. 12. 31. -2.38% = -2.16 × 0.89 × 2.53% × 0.49
2024. 9. 30. -2.16% = -1.85 × 0.87 × 2.80% × 0.48
2024. 6. 30. -2.43% = -2.28 × 0.84 × 2.48% × 0.51
2024. 3. 31. 16.81% = 0.84 × 0.99 × 47.23% × 0.43
2023. 12. 31. 15.92% = 0.83 × 0.99 × 44.83% × 0.43
2023. 9. 30. 15.97% = 0.81 × 0.99 × 45.10% × 0.44
2023. 6. 30. 16.54% = 0.78 × 0.99 × 45.81% × 0.47
2023. 3. 31. 17.18% = 0.78 × 0.99 × 45.83% × 0.49
2022. 12. 31. 18.30% = 0.78 × 0.99 × 48.01% × 0.49
2022. 9. 30. 19.59% = 0.81 × 0.99 × 46.95% × 0.52
2022. 6. 30. 20.50% = 0.81 × 0.99 × 47.81% × 0.54
2022. 3. 31. 17.19% = 0.86 × 0.98 × 36.80% × 0.56
2021. 12. 31. 17.44% = 0.86 × 0.98 × 36.86% × 0.56
2021. 9. 30. 17.25% = 0.79 × 0.98 × 39.42% × 0.57
2021. 6. 30. 16.30% = 0.83 × 0.98 × 36.99% × 0.55
2021. 3. 31. 22.80% = 0.84 × 0.98 × 52.07% × 0.53
2020. 12. 31. 23.07% = 0.87 × 0.98 × 51.16% × 0.53
2020. 9. 30. — = — × — × — × —
2020. 6. 30. — = — × — × — × —
2020. 3. 31. — = — × — × — × —

보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-Q (보고 날짜: 2024-09-30), 10-Q (보고 날짜: 2024-06-30), 10-Q (보고 날짜: 2024-03-31), 10-K (보고 날짜: 2023-12-31), 10-Q (보고 날짜: 2023-09-30), 10-Q (보고 날짜: 2023-06-30), 10-Q (보고 날짜: 2023-03-31), 10-K (보고 날짜: 2022-12-31), 10-Q (보고 날짜: 2022-09-30), 10-Q (보고 날짜: 2022-06-30), 10-Q (보고 날짜: 2022-03-31), 10-K (보고 날짜: 2021-12-31), 10-Q (보고 날짜: 2021-09-30), 10-Q (보고 날짜: 2021-06-30), 10-Q (보고 날짜: 2021-03-31), 10-K (보고 날짜: 2020-12-31), 10-Q (보고 날짜: 2020-09-30), 10-Q (보고 날짜: 2020-06-30), 10-Q (보고 날짜: 2020-03-31).

순이익률(Net Profit Margin Ratio)의 세분화

Vertex Pharmaceuticals Inc., 순이익률의 분해(분기별 데이터)

Microsoft Excel
순이익률(Net Profit Margin Ratio) = 세금 부담 × 이자 부담 × EBIT 마진
2024. 12. 31. -4.86% = -2.16 × 0.89 × 2.53%
2024. 9. 30. -4.52% = -1.85 × 0.87 × 2.80%
2024. 6. 30. -4.74% = -2.28 × 0.84 × 2.48%
2024. 3. 31. 39.46% = 0.84 × 0.99 × 47.23%
2023. 12. 31. 36.68% = 0.83 × 0.99 × 44.83%
2023. 9. 30. 35.94% = 0.81 × 0.99 × 45.10%
2023. 6. 30. 35.40% = 0.78 × 0.99 × 45.81%
2023. 3. 31. 35.40% = 0.78 × 0.99 × 45.83%
2022. 12. 31. 37.20% = 0.78 × 0.99 × 48.01%
2022. 9. 30. 37.62% = 0.81 × 0.99 × 46.95%
2022. 6. 30. 38.26% = 0.81 × 0.99 × 47.81%
2022. 3. 31. 30.84% = 0.86 × 0.98 × 36.80%
2021. 12. 31. 30.92% = 0.86 × 0.98 × 36.86%
2021. 9. 30. 30.52% = 0.79 × 0.98 × 39.42%
2021. 6. 30. 29.80% = 0.83 × 0.98 × 36.99%
2021. 3. 31. 43.06% = 0.84 × 0.98 × 52.07%
2020. 12. 31. 43.70% = 0.87 × 0.98 × 51.16%
2020. 9. 30. — = — × — × —
2020. 6. 30. — = — × — × —
2020. 3. 31. — = — × — × —

보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-Q (보고 날짜: 2024-09-30), 10-Q (보고 날짜: 2024-06-30), 10-Q (보고 날짜: 2024-03-31), 10-K (보고 날짜: 2023-12-31), 10-Q (보고 날짜: 2023-09-30), 10-Q (보고 날짜: 2023-06-30), 10-Q (보고 날짜: 2023-03-31), 10-K (보고 날짜: 2022-12-31), 10-Q (보고 날짜: 2022-09-30), 10-Q (보고 날짜: 2022-06-30), 10-Q (보고 날짜: 2022-03-31), 10-K (보고 날짜: 2021-12-31), 10-Q (보고 날짜: 2021-09-30), 10-Q (보고 날짜: 2021-06-30), 10-Q (보고 날짜: 2021-03-31), 10-K (보고 날짜: 2020-12-31), 10-Q (보고 날짜: 2020-09-30), 10-Q (보고 날짜: 2020-06-30), 10-Q (보고 날짜: 2020-03-31).